Sökning: onr:"swepub:oai:lup.lub.lu.se:7efe5bbf-0ff7-4f5a-894b-0299ccb2dff7" > Splanchnic vein thr...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05071naa a2200673 4500 | |
001 | oai:lup.lub.lu.se:7efe5bbf-0ff7-4f5a-894b-0299ccb2dff7 | |
003 | SwePub | |
008 | 161207s2016 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/7efe5bbf-0ff7-4f5a-894b-0299ccb2dff72 URI |
024 | 7 | a https://doi.org/10.1038/bcj.2016.1032 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a De Stefano, V.u Catholic University of the Sacred Heart, Rome4 aut |
245 | 1 0 | a Splanchnic vein thrombosis in myeloproliferative neoplasms : Risk factors for recurrences in a cohort of 181 patients |
264 | c 2016-11-04 | |
264 | 1 | b Springer Science and Business Media LLC,c 2016 |
520 | a We retrospectively studied 181 patients with polycythaemia vera (n=67), essential thrombocythaemia (n=67) or primary myelofibrosis (n=47), who presented a first episode of splanchnic vein thrombosis (SVT). Budd-Chiari syndrome (BCS) and portal vein thrombosis were diagnosed in 31 (17.1%) and 109 (60.3%) patients, respectively; isolated thrombosis of the mesenteric or splenic veins was detected in 18 and 23 cases, respectively. After this index event, the patients were followed for 735 patient years (pt-years) and experienced 31 recurrences corresponding to an incidence rate of 4.2 per 100 pt-years. Factors associated with a significantly higher risk of recurrence were BCS (hazard ratio (HR): 3.03), history of previous thrombosis (HR: 3.62), splenomegaly (HR: 2.66) and leukocytosis (HR: 2.8). Vitamin K-antagonists (VKA) were prescribed in 85% of patients and the recurrence rate was 3.9 per 100 pt-years, whereas in the small fraction (15%) not receiving VKA more recurrences (7.2 per 100 pt-years) were reported. Intracranial and extracranial major bleeding was recorded mainly in patients on VKA and the corresponding rate was 2.0 per 100 pt-years. In conclusion, despite anticoagulation treatment, the recurrence rate after SVT in myeloproliferative neoplasms is high and suggests the exploration of new avenues of secondary prophylaxis with new antithrombotic drugs and JAK-2 inhibitors. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng |
700 | 1 | a Vannucchi, A. M.u University of Florence4 aut |
700 | 1 | a Ruggeri, M.u Ospedale San Bortolo4 aut |
700 | 1 | a Cervantes, F.u Institutd' Investigacions Biomèdiques August Pi iSunyer (IDIBAPS)4 aut |
700 | 1 | a Alvarez-Larrán, A.u Hospital del Mar Medical Research Institute4 aut |
700 | 1 | a Iurlo, A.u Maggiore Hospital Policlinico4 aut |
700 | 1 | a Randi, M. L.u University of Padova4 aut |
700 | 1 | a Pieri, L.u University of Florence4 aut |
700 | 1 | a Rossi, E.u Catholic University of the Sacred Heart, Rome4 aut |
700 | 1 | a Guglielmelli, P.u University of Florence4 aut |
700 | 1 | a Betti, S.u Catholic University of the Sacred Heart, Rome4 aut |
700 | 1 | a Elli, E.u University of Milano-Bicocca4 aut |
700 | 1 | a Finazzi, M. C.u Papa Giovanni XXIII Hospital4 aut |
700 | 1 | a Finazzi, G.u Papa Giovanni XXIII Hospital4 aut |
700 | 1 | a Zetterberg, E.u Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)med-ezt |
700 | 1 | a Vianelli, N.u St. Orsola-Malpighi University Hospital4 aut |
700 | 1 | a Gaidano, G.u University of Eastern Piedmont4 aut |
700 | 1 | a Nichele, I.u Ospedale San Bortolo4 aut |
700 | 1 | a Cattaneo, D.u Maggiore Hospital Policlinico4 aut |
700 | 1 | a Palova, M.u University Hospital of Olomouc4 aut |
700 | 1 | a Ellis, M. H.u Meir Medical Center4 aut |
700 | 1 | a Cacciola, E.u University of Catania4 aut |
700 | 1 | a Tieghi, A.u Arcispedale Santa Maria Nuova4 aut |
700 | 1 | a Hernandez-Boluda, J. C.u University and Polytechnic Hospital la Fe4 aut |
700 | 1 | a Pungolino, E.u Niguarda Hospital4 aut |
700 | 1 | a Specchia, G.u Bari University Hospital4 aut |
700 | 1 | a Rapezzi, D.u A.O. Santa Croce e Carle4 aut |
700 | 1 | a Forcina, A.u San Raffaele Scientific Institute4 aut |
700 | 1 | a Musolino, C.u Bari University Hospital4 aut |
700 | 1 | a Carobbio, A.u Papa Giovanni XXIII Hospital4 aut |
700 | 1 | a Griesshammer, M.u Ruhr-University Bochum4 aut |
700 | 1 | a Barbui, T.u Papa Giovanni XXIII Hospital4 aut |
710 | 2 | a Catholic University of the Sacred Heart, Romeb University of Florence4 org |
773 | 0 | t Blood Cancer Journald : Springer Science and Business Media LLCg 6:11q 6:11x 2044-5385 |
856 | 4 | u http://dx.doi.org/10.1038/bcj.2016.103x freey FULLTEXT |
856 | 4 | u https://www.nature.com/articles/bcj2016103.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/7efe5bbf-0ff7-4f5a-894b-0299ccb2dff7 |
856 | 4 8 | u https://doi.org/10.1038/bcj.2016.103 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy